Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for neurological disorders. A number of drug development programs are currently being conducted to evaluate our drug candidates in diseases such as bipolar disorder and Friedreich's ataxia.
Repligen Corporation
41 Seyon Street
Building #1, Suite 100
Waltham, MA
02453
USA
view on map
http://www.repligen.com
info@repligen.com
(781) 250-0111
Type:
Industry
